Glia and zinc in ageing and Alzheimer's disease: a mechanism for cognitive decline?
- PMID: 25009495
- PMCID: PMC4069481
- DOI: 10.3389/fnagi.2014.00137
Glia and zinc in ageing and Alzheimer's disease: a mechanism for cognitive decline?
Abstract
Normal ageing is characterized by cognitive decline across a range of neurological functions, which are further impaired in Alzheimer's disease (AD). Recently, alterations in zinc (Zn) concentrations, particularly at the synapse, have emerged as a potential mechanism underlying the cognitive changes that occur in both ageing and AD. Zn is now accepted as a potent neuromodulator, affecting a variety of signaling pathways at the synapse that are critical to normal cognition. While the focus has principally been on the neuron: Zn interaction, there is a growing literature suggesting that glia may also play a modulatory role in maintaining both Zn ion homeostasis and the normal function of the synapse. Indeed, zinc transporters (ZnT's) have been demonstrated in glial cells where Zn has also been shown to have a role in signaling. Furthermore, there is increasing evidence that the pathogenesis of AD critically involves glial cells (such as astrocytes), which have been reported to contribute to amyloid-beta (Aβ) neurotoxicity. This review discusses the current evidence supporting a complex interplay of glia, Zn dyshomeostasis and synaptic function in ageing and AD.
Keywords: Alzheimer disease; ageing (aging); astrocyte-neuron interactions; microglia; synapse regulation; zinc.
Figures



Similar articles
-
Metabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's Disease.Cell Mol Neurobiol. 2022 Nov;42(8):2527-2551. doi: 10.1007/s10571-021-01147-7. Epub 2021 Sep 13. Cell Mol Neurobiol. 2022. PMID: 34515874 Free PMC article. Review.
-
Regulation of extracellular Zn(2+) homeostasis in the hippocampus as a therapeutic target for Alzheimer's disease.Expert Opin Ther Targets. 2015;19(8):1051-8. doi: 10.1517/14728222.2015.1029454. Epub 2015 Mar 27. Expert Opin Ther Targets. 2015. PMID: 25818846 Review.
-
Is interaction of amyloid β-peptides with metals involved in cognitive activity?Metallomics. 2015 Aug;7(8):1205-12. doi: 10.1039/c5mt00076a. Metallomics. 2015. PMID: 25959547 Review.
-
Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction.Front Aging Neurosci. 2021 Jun 15;13:653334. doi: 10.3389/fnagi.2021.653334. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34211387 Free PMC article.
-
Molecular mechanism of zinc neurotoxicity in Alzheimer's disease.Environ Sci Pollut Res Int. 2020 Dec;27(35):43542-43552. doi: 10.1007/s11356-020-10477-w. Epub 2020 Sep 9. Environ Sci Pollut Res Int. 2020. PMID: 32909132 Review.
Cited by
-
Editorial: The molecular pathology of cognitive decline: focus on metals.Front Aging Neurosci. 2015 Jun 17;7:116. doi: 10.3389/fnagi.2015.00116. eCollection 2015. Front Aging Neurosci. 2015. PMID: 26136683 Free PMC article. No abstract available.
-
Astrocytes in heavy metal neurotoxicity and neurodegeneration.Brain Res. 2021 Feb 1;1752:147234. doi: 10.1016/j.brainres.2020.147234. Epub 2021 Jan 5. Brain Res. 2021. PMID: 33412145 Free PMC article. Review.
-
Identification of Cerebral Metal Ion Imbalance in the Brain of Aging Octodon degus.Front Aging Neurosci. 2017 Mar 29;9:66. doi: 10.3389/fnagi.2017.00066. eCollection 2017. Front Aging Neurosci. 2017. PMID: 28405187 Free PMC article.
-
Zinc Supplementation Improves ZIP14 (SLC39A14) Levels in Cerebral Cortex Suppressed by icv-STZ Injection.Noro Psikiyatr Ars. 2024 Feb 20;61(1):11-14. doi: 10.29399/npa.28426. eCollection 2024. Noro Psikiyatr Ars. 2024. PMID: 38496222 Free PMC article.
-
Astrocyte heterogeneity in the brain: from development to disease.Front Cell Neurosci. 2015 Mar 20;9:76. doi: 10.3389/fncel.2015.00076. eCollection 2015. Front Cell Neurosci. 2015. PMID: 25852472 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources